UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 665

Sortiert nach

The Metabolic Syndrome: Inflammation, Diabetes Mellitus, and Cardiovascular Disease

The American journal of cardiology, 2006-01, Vol.97 (2), p.3-11

Haffner, Steven M.

2006

Volltextzugriff (PDF)

Risk of Developing Diabetes and Cardiovascular Disease in Metabolically Unhealthy Normal-Weight and Metabolically Healthy Obese Individuals

The journal of clinical endocrinology and metabolism, 2014-02, Vol.99 (2), p.462-468

2014

Volltextzugriff (PDF)

Abdominal Adiposity and Cardiometabolic Risk: Do We Have All the Answers?

The American journal of medicine, 2007-09, Vol.120 (9), p.S10-S16

Haffner, Steven M., MD

2007

Volltextzugriff (PDF)

National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes

Diabetes care, 2007, Vol.30 (1), p.8-13

2007

Volltextzugriff (PDF)

Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS)

Diabetes care, 2016-04, Vol.39 (4), p.582-588

2016

Volltextzugriff (PDF)

Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)

The American journal of cardiology, 2015-02, Vol.115 (3), p.307-315

2015

Volltextzugriff (PDF)

Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men

Diabetes (New York, N.Y.), 2009-05, Vol.58 (5), p.1212-1221

2009

Volltextzugriff (PDF)

Sleep Duration as a Risk Factor for Incident Type 2 Diabetes in a Multiethnic Cohort

Annals of epidemiology, 2009-05, Vol.19 (5), p.351-357

2009

Volltextzugriff (PDF)

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

The New England journal of medicine, 2006-12, Vol.355 (23), p.2427-2443

2006

Volltextzugriff (PDF)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis

The Lancet (British edition), 2014-03, Vol.383 (9922), p.1059-1066

2014

Volltextzugriff (PDF)

Relationship of metabolic risk factors and development of cardiovascular disease and diabetes

Obesity (Silver Spring, Md.), 2006-06, Vol.14 (6s), p.121S-127S

Haffner, S.M

2006

Volltextzugriff (PDF)

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

Diabetes (New York, N.Y.), 2003-05, Vol.52 (5), p.1210-1214

2003

Volltextzugriff (PDF)

Insulin resistance, inflammation, and the prediabetic state

The American journal of cardiology, 2003-08, Vol.92 (4), p.18-26

Haffner, Steven M

2003

Volltextzugriff (PDF)

Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study

Diabetologia, 2014-07, Vol.57 (7), p.1366-1374

2014

Volltextzugriff (PDF)

Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?

Diabetes care, 2004-11, Vol.27 (11), p.2676-2681

2004

Volltextzugriff (PDF)

Relation of Direct and Surrogate Measures of Insulin Resistance to Cardiovascular Risk Factors in Nondiabetic Finnish Offspring of Type 2 Diabetic Individuals

The journal of clinical endocrinology and metabolism, 2010-11, Vol.95 (11), p.5082-5090

2010

Volltextzugriff (PDF)

Adherence to the DASH Diet Is Inversely Associated With Incidence of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study

Diabetes care, 2009-08, Vol.32 (8), p.1434-1436

2009

Volltextzugriff (PDF)

Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women

Endocrine reviews, 2007-12, Vol.28 (7), p.763-777

2007

Volltextzugriff (PDF)

Elevated Depression Symptoms, Antidepressant Medicine Use, and Risk of Developing Diabetes During the Diabetes Prevention Program

Diabetes care, 2008-03, Vol.31 (3), p.420-426

2008

Volltextzugriff (PDF)

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

Annals of internal medicine, 2002-04, Vol.136 (8), p.575

2002

Volltextzugriff (PDF)

Impaired Fasting Glucose and Impaired Glucose Tolerance Have Distinct Lipoprotein and Apolipoprotein Changes: The Insulin Resistance Atherosclerosis Study

The journal of clinical endocrinology and metabolism, 2013-04, Vol.98 (4), p.1622-1630

2013

Volltextzugriff (PDF)

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline

The journal of clinical endocrinology and metabolism, 2008-10, Vol.93 (10), p.3671-3689

2008

Volltextzugriff (PDF)

Individual serum saturated fatty acids and markers of chronic subclinical inflammation: the Insulin Resistance Atherosclerosis Study

Journal of lipid research, 2017-11, Vol.58 (11), p.2171-2179

2017

Volltextzugriff (PDF)

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus

Journal of the American Heart Association, 2020-10, Vol.9 (19), p.e017462-e017462

2020

Volltextzugriff (PDF)

Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study

Diabetes care, 2002-11, Vol.25 (11), p.2016-2021

2002

Volltextzugriff (PDF)

1 – 25 von 665

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(641)
Mit Volltextzugriff
(538)

Publikationsform

Sprache

Englisch
(665)
Japanisch
(153)

Erscheinungsjahr

n.n

Thema

Humans
(516)
Science & Technology
(457)
Life Sciences & Biomedicine
(454)
Male
(399)
Female
(391)
Middle Aged
(362)
Biological And Medical Sciences
(339)
Medical Sciences
(325)
Adult
(254)
Risk Factors
(233)
Diabetes
(216)
Endocrinology & Metabolism
(212)
Endocrinopathies
(198)
Diabetes. Impaired Glucose Tolerance
(191)
Endocrine Pancreas. Apud Cells
(191)
Insulin Resistance
(184)
Aged
(142)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(123)
Body Mass Index
(120)
Cardiovascular System & Cardiology
(109)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Metabolic Syndrome: Inflammation, Diabetes Mellitus, and Cardiovascular Disease

Risk of Developing Diabetes and Cardiovascular Disease in Metabolically Unhealthy Normal-Weight and Metabolically Healthy Obese Individuals

Abdominal Adiposity and Cardiometabolic Risk: Do We Have All the Answers?

National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes

Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS)

Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)

Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men

Sleep Duration as a Risk Factor for Incident Type 2 Diabetes in a Multiethnic Cohort

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis

Relationship of metabolic risk factors and development of cardiovascular disease and diabetes

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

Insulin resistance, inflammation, and the prediabetic state

Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study

Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?

Relation of Direct and Surrogate Measures of Insulin Resistance to Cardiovascular Risk Factors in Nondiabetic Finnish Offspring of Type 2 Diabetic Individuals

Adherence to the DASH Diet Is Inversely Associated With Incidence of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study

Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women

Elevated Depression Symptoms, Antidepressant Medicine Use, and Risk of Developing Diabetes During the Diabetes Prevention Program

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

Impaired Fasting Glucose and Impaired Glucose Tolerance Have Distinct Lipoprotein and Apolipoprotein Changes: The Insulin Resistance Atherosclerosis Study

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline

Individual serum saturated fatty acids and markers of chronic subclinical inflammation: the Insulin Resistance Atherosclerosis Study

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus

Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study

Suchergebnisse filtern